VIFOR PHARMA

HQ: Glattbrugg (near Zürich), Switzerland

Founded in: 1944

Web: www.viforpharma.ch/en

Vifor Pharma Switzerland is a fully integrated pharmaceutical company within the Vifor Pharma Group primarily. It concentrates on the widespread condition of iron deficiency and specialty medications in a number of therapeutic areas.

The company’s main areas of business are:

  • Regulatory affairs
  • Early market access programmes
  • Pricing and reimbursement
  • Launch readiness
  • Partner management
  • Individual product support by specialised resources: marketing, medical liaison, key account management, sales force and distribution
  • Expertise in many therapeutic areas and with leading products (i.e. originals, generics, drug device combinations, orphan drugs).

Therapeutic Areas

  • Iron deficiency
  • Renal insufficiency and its consequences
  • Depression
  • Mild cognitive impairment
  • Menopause
  • Urinary tract infections
  • Respiratory tract infections
  • Cystic fibrosis
  • Alpha-1 antitrypsin deficiency
  • Crohn’s disease, ulcerative colitis
  • Oncology and supportive care

Target groups

  • Retail and hospital
  • General practitioners
  • Consultants and speicialists
  • Cystic fibrosis centres

Business Units

  • Cardiology, Nephrology & Oncology, Primary Care, Gynaecology & Gastroenterology (All based in Villars-sur-Glâne, Switzerland)

Key data

  • Net sales: CHF 123.7m (2017)
  • Employees: 94

Contact

VIFOR SA
Mrs. Gabrielle Gache
Head of Strategy and BD&L OM Pharma
Route du Moncor 10
1752 Villars-sur-Glâne
Switzerland

T: +41 22 783 11 11
F: +41 22 783 11 22
E: gabrielle.gache@viforpharma.com
I: www.viforpharma.com

Route du Moncor 10
CH-1752 Villars-sur-Glâne